Medication info
M-Shoobet 25 mg (Empagliflozin 2L-Proline)

M-Shoobet 25 mg (Empagliflozin 2L-Proline)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin 2L-Proline›37.766mg / 1 tablet
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
Light yellow, biconvex, oval film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202502438 · Approved 2025.09.15

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 10 mg once daily, both as monotherapy and as add-on combination therapy with other blood glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is administered concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, section 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations •Patients with renal impairment This medicine is not recommended for patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2 for the purpose of improving glycemic control. No dose adjustment is required in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Do not use this medicine in patients with end-stage renal disease (ESRD) or those receiving dialysis, as efficacy is not expected in these patients. •Patients with hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment because it has not been studied in these patients. •Older adults No dose adjustment is required based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older (see Precautions for Use, section 4. General Precautions).

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • blood sugar control disorder
  • cardiovascular disease
View approved original text

This medication is used to improve blood sugar control in adults with type 2 diabetes. It is administered as an adjunct to diet and exercise and can be used as monotherapy or in combination with other medications. It is particularly effective in patients whose blood sugar is not adequately controlled. Additionally, it is recommended for safe use based on clinical trial information regarding the occurrence of cardiovascular events in patients with type 2 diabetes accompanied by cardiovascular disease. This medication helps improve patients' health by aiding diabetes management through blood sugar control.

How to take

Adult dose

The recommended dose of this medicine is 10 mg once daily, both as monotherapy and as add-on combination therapy with other blood glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is administered concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, section 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations •Patients with renal impairment This medicine is not recommended for patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2 for the purpose of improving glycemic control. No dose adjustment is required in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Do not use this medicine in patients with end-stage renal disease (ESRD) or those receiving dialysis, as efficacy is not expected in these patients. •Patients with hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment because it has not been studied in these patients. •Older adults No dose adjustment is required based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older (see Precautions for Use, section 4. General Precautions).

Precautions

This medication should not be administered to specific patients. First, patients who are allergic to the main ingredient or components of this medication should not take it. Patients with type 1 diabetes or diabetic ketoacidosis may also be at risk if they use this medication. Furthermore, patients with lactose intolerance or genetic galactose metabolism disorders should not take this medication due to the lactose it contains. Patients with impaired kidney function should use this medication cautiously. In particular, in patients with significantly reduced kidney function, the effectiveness of this medication may diminish, or the risk of side effects may increase; thus, regular kidney function testing is required. Patients with chronic heart failure or chronic kidney disease should also consult their doctor sufficiently before using this medication. The risk of hypoglycemia may increase when this medication is used in conjunction with blood sugar-lowering medications such as insulin or sulfonylureas; therefore, dosage adjustments may be necessary when combined with such medications. Major side effects that may occur while taking this medication include hypoglycemia, genital infections, urinary tract infections, increased urination, decreased fluid volume, liver function abnormalities, etc. Hypoglycemia, in particular, may occur more frequently when taken with insulin or sulfonylureas, so caution is advised. Serious metabolic disorders such as ketoacidosis may rarely occur in association with this medication; thus, if symptoms such as nausea, vomiting, abdominal pain, or difficulty in breathing appear, it is essential to inform medical personnel immediately. Additionally, elderly patients or those with cardiovascular disease who are at risk of fluid loss or low blood pressure should closely monitor their fluid status while taking this medication. This medication may impact liver function; therefore, patients with liver disease should consult their doctor before taking it. Caution is necessary while driving or operating machinery, as this medication may increase the risk of hypoglycemia. Pregnant women or nursing mothers are advised to avoid taking this medication, and it should be discontinued immediately if pregnancy is confirmed. Additionally, the safety and efficacy of this medication have not been established in children under 18 years of age. There have been no reported special toxicities in the case of overdose, however, if overdose occurs, immediate medical attention should be sought for appropriate treatment. This medication must be stored out of reach of children, and it is crucial to avoid transferring it to other containers to maintain safety and quality.

Side effects

  • Hypoglycemia
  • ketoacidosis
  • constipation
  • itching
  • rash
  • urticaria
  • angioedema
  • decreased fluid volume
  • increased urination
  • difficulty urinating
Show 204 more
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • vulvovaginitis
  • balanitis
  • other genital infections
  • urinary tract infection
  • perineal necrosis
  • urosepsis
  • pyelonephritis
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • gastrointestinal bleeding
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • sepsis
  • subcutaneous abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • cervicitis
  • hyperglycemia
  • hyponatremia
  • diabetic foot
  • back pain
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • tear-associated retinal detachment
  • limb injury
  • road traffic accident
  • splenic injury
  • sternal fracture
  • angina
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • benign neoplasm of the ampulla of Vater
  • benign ovarian tumor
  • bladder cancer
  • gastric cancer
  • pancreatic carcinoma
  • colorectal cancer
  • thyroid cancer
  • uterine leiomyoma
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • unstable angina
  • abdominal pain
  • dental caries
  • erosive gastritis
  • abdominal discomfort
  • gastroesophageal reflux disease
  • abdominal distension
  • rectal bleeding
  • chronic gastritis
  • enteritis
  • bloating
  • gastric polyp
  • gingival swelling
  • passage of blood in stool
  • hemorrhoids
  • pancreatic cyst
  • rectal pain
  • toothache
  • dyspepsia
  • upper respiratory infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • tinea corporis
  • dental abscess
  • nasopharyngitis
  • positional dizziness
  • sensory loss
  • perceptual distortions
  • amnesia
  • diabetic neuropathy
  • facial paralysis
  • memory disturbances
  • neuralgia
  • Parkinsonism
  • polyneuropathy
  • drowsiness
  • fatigue
  • peripheral edema
  • facial swelling
  • peripheral swelling
  • chills
  • strange sensations
  • edema
  • pain
  • pain at the puncture site
  • weight gain
  • abnormal electrocardiogram
  • decreased hemoglobin
  • increased hemoglobin
  • positive Helicobacter test
  • positive urine red blood cells
  • hematuria
  • overactive bladder
  • renal mass
  • urinary retention
  • urinary pain
  • abnormal urination
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • scrotal pain
  • sexual dysfunction
  • vaginal discharge
  • decreased appetite
  • obesity
  • vitamin D deficiency
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • prickly heat
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • ocular discomfort
  • conjunctival injection
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • age-related dyspnea
  • wet cough
  • allergic rhinitis
  • residual sputum
  • skin lacerations
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • falls
  • hand fracture
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • anxiety
  • depression
  • sleep disorders
  • ear pain
  • positional vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • vulvar pruritus
  • genital pruritus
  • diabetic retinopathy
  • dry eyes
  • cough
  • dyspnea
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius. This way, the effectiveness and safety of the medication can be preserved for a longer period.

Appearance and packaging

Appearance

Light yellow, biconvex, oval film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.